NorthWest Biotherapeutics Inc (NWBO)

[iclight]

50/1000 = 5% which is the 5 year survival of the total GBM population.

So even if the 50/331 was from the DCVax trial that’s only 15% which is what I’d expect when you take out the sickest patients using the inclusion/exclusion criteria of the trial.

If anything it just indicates trials in sub populations which is how I expect them to release data. “We think there is benefit in some sub population so we need to further analyze the data”